Flagship Healthcare Trust, Inc.
Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.
Raised
$95M
Investors
204
Min Invest
None stated
Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.
What this filing shows
·Every sentence is a value as filed on SEC Form D
Flagship Healthcare Trust, Inc. is a Maryland corporation that first filed a Form D on February 5, 2018 and most recently amended it on May 22, 2026 in the REITS and Finance industry group. The offering claims Section 3(c), Section 3(c)(1), 3C.5, Section 3(c)(7) and covers equity and pooled investment fund interests. Flagship Healthcare Trust, Inc. reported $95,060,171 sold from 204 investors of a $500,000,000 total offering as of the Form D filed May 22, 2026. The filing states that the figure is combined across related vehicles, so it is not this entity's figure alone. The filing checks both Section 3(c)(1), which caps the fund at 100 beneficial owners, and Section 3(c)(7), which requires every investor to be a qualified purchaser, generally an individual with at least $5 million in investments. A fund normally relies on one or the other. The filing reports no non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated. The Form D names Jeffrey Scott Spray (CRD 2100346), associated with INNOVATION PARTNERS LLC; Jeffrey Scott Spray (CRD 2100346), associated with FNEX CAPITAL, LLC as recipients of sales compensation soliciting in AL, AR, AZ, CA, FL, GA, IL, LA, MA, MI, MN, MO, NC, NV, NY, OH, OK, PA, SC, TN, TX, UT, VA. Sales commissions are reported as $325,600 and finders' fees as $0. Form D allows these to be estimates. The issuer's address of record is 2701 Coltsgate Road, Suite 300, Charlotte, NC 28211.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govFilings on Record
Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.
In the Terminal
Filing events
6
latest May 22, 2026
Critical / warning
0 / 1
5 watch · 0 info
Statements extracted
0
none on file
NAV prints
0
none on file
Offering chains
2
closed, raising
Latest event Sold increase · May 22, 2026
SEC.govInvestor
- 6 filing events with values and deltas, latest 2026-05-22, and alerts on the next one
- 2 offering timelines: velocity, share raised, first-sale lag, stalled flags
Pro
- This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
- The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV
Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…
Related Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
J. Brannen Edge III
Executive Officer, Director · Charlotte, NC
Chief Executive Officer and Director of the Issuer
M. Hunt Broyhill
Director · Charlotte, NC
Theresa Hunt Gebhardt
Director · Charlotte, NC
Nelson Hunt Schwab III
Director · Charlotte, NC
Bradley H. Carroll
Director · Charlotte, NC
Kyle H. Sweeney
Executive Officer, Director · Charlotte, NC
Vice President and Director
William K. Tate, III
Executive Officer · Charlotte, NC
Secretary
Placement Agents and Sales Compensation (Form D)
Who the issuer reported paying to sell the securities (Form D Item 12), with the FINRA registration number the filer gave. Source: SEC.gov.
Jeffrey Scott SprayCRD 2100346 on BrokerCheck
Associated broker-dealer: INNOVATION PARTNERS LLC (CRD 146344) · Charlotte, NC · Soliciting in AL, AR, AZ, CA, FL, GA, IL, LA, MA, MI, MN, MO, NC, NV, NY, OH, OK, PA, SC, TN, TX, UT, VA
Jeffrey Scott SprayCRD 2100346 on BrokerCheck
Associated broker-dealer: FNEX CAPITAL, LLC (CRD 166316) · Indianapolis, IN · Soliciting in AL, AR, AZ, CA, FL, GA, IL, LA, MA, MI, MN, MO, NC, NV, NY, OH, OK, PA, SC, TN, TX, UT, VA
Questions About Flagship Healthcare Trust, Inc.
Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.
What is Flagship Healthcare Trust, Inc.?
Flagship Healthcare Trust, Inc. is a Maryland corporation that filed a Form D with the SEC on May 22, 2026 in the REITS and Finance industry group. The filing claims Section 3(c), Section 3(c)(1), 3C.5, Section 3(c)(7) for an offering of equity and pooled investment fund interests.
Is Flagship Healthcare Trust, Inc. legit?
AltStreet does not rate legitimacy; it reports the public record. Flagship Healthcare Trust, Inc. filed a Form D with the SEC on May 22, 2026 claiming Section 3(c), Section 3(c)(1), 3C.5, Section 3(c)(7). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $95,060,171 sold to 204 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.
Is Flagship Healthcare Trust, Inc. registered with or approved by the SEC?
No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that Flagship Healthcare Trust, Inc. claimed Section 3(c), Section 3(c)(1), 3C.5, Section 3(c)(7) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.
How much has Flagship Healthcare Trust, Inc. raised?
Flagship Healthcare Trust, Inc. reported $95,060,171 sold from 204 investors of a $500,000,000 total offering as of the Form D filed May 22, 2026. The filing states that the figure is combined across related vehicles, so it is not this entity's figure alone.
Who can invest in Flagship Healthcare Trust, Inc.?
The filing checks both Section 3(c)(1), which caps the fund at 100 beneficial owners, and Section 3(c)(7), which requires every investor to be a qualified purchaser, generally an individual with at least $5 million in investments. A fund normally relies on one or the other. The filing reports no non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated.
What is the minimum investment in Flagship Healthcare Trust, Inc.?
The Form D lists the minimum investment as $0, which means the issuer did not state a minimum on the form. The offering documents, not the Form D, set the actual subscription terms.
Who is selling Flagship Healthcare Trust, Inc. and how are they paid?
The Form D names Jeffrey Scott Spray (CRD 2100346), associated with INNOVATION PARTNERS LLC; Jeffrey Scott Spray (CRD 2100346), associated with FNEX CAPITAL, LLC as recipients of sales compensation soliciting in AL, AR, AZ, CA, FL, GA, IL, LA, MA, MI, MN, MO, NC, NV, NY, OH, OK, PA, SC, TN, TX, UT, VA. Sales commissions are reported as $325,600 and finders' fees as $0. Form D allows these to be estimates.
Who is behind Flagship Healthcare Trust, Inc.?
The Form D lists 7 related persons: J. Brannen Edge III, executive officer, director (Chief Executive Officer and Director of the Issuer); M. Hunt Broyhill, director; Theresa Hunt Gebhardt, director; Nelson Hunt Schwab III, director; Bradley H. Carroll, director; Kyle H. Sweeney, executive officer, director (Vice President and Director); William K. Tate, III, executive officer (Secretary). Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.
Where is Flagship Healthcare Trust, Inc. located?
The issuer's address on its SEC filings is 2701 Coltsgate Road, Suite 300, Charlotte, NC 28211. Its phone number of record is (704) 442-0222. It is organized under the laws of Maryland.
How long is the Flagship Healthcare Trust, Inc. offering open?
The issuer indicated that the offering is intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open; 3 amendments are on record for this CIK.
What is Flagship Healthcare Trust, Inc.'s revenue?
The issuer declined to disclose its revenue range on the Form D, which the form permits.

Is this your company or fund?
Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.
Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
